Gene Summary
IMPC Data Collections
- Body Weight Measurements
- No Embryo Imaging Data
- Viability Data
The IMPC applies a panel of phenotyping screens to characterise single-gene knockout mice by comparison to wild types. Click on the different tabs to visualise significant phenotypes identified by the IMPC, as well as all data that was measured.
Phenotype | System | Allele | Zyg | Sex | Life Stage | P Value |
---|---|---|---|---|---|---|
increased freezing behavior | BC048562tm1b(KOMP)Wtsi | HOM | Late adult | 6.23×10-05 | ||
decreased locomotor activity | BC048562tm1b(KOMP)Wtsi | HOM | Late adult | 3.28×10-06 | ||
abnormal sensory capabilities/reflexes/nociception | BC048562tm1b(KOMP)Wtsi | HOM | Early adult | 3.13×10-05 * | ||
decreased locomotor activity | BC048562tm1b(KOMP)Wtsi | HOM | Early adult | 2.75×10-06 | ||
decreased fasting circulating glucose level | BC048562tm1b(KOMP)Wtsi | HOM | Late adult | 1.12×10-05 | ||
abnormal locomotor behavior | BC048562tm1b(KOMP)Wtsi | HOM | Early adult | 1.57×10-05 |
An assay measuring the expression of lacZ shows the tissue where the gene is expressed.
Anatomy | Images | Zygosity | Mutant Expr |
---|---|---|---|
Ovary | Wholemount images | heterozygote | 50% (1 of 2) |
Adrenal gland | N/A | heterozygote | 0.0% (0 of 2) |
Aorta | N/A | heterozygote | 0.0% (0 of 2) |
Bone | N/A | heterozygote | 0.0% (0 of 2) |
Brain | N/A | heterozygote | 0.0% (0 of 2) |
Brainstem | N/A | heterozygote | 0.0% (0 of 2) |
Brown adipose tissue | N/A | heterozygote | 0.0% (0 of 2) |
Cartilage tissue | N/A | heterozygote | 0.0% (0 of 2) |
Cerebellum | N/A | heterozygote | 0.0% (0 of 2) |
Cerebral cortex | N/A | heterozygote | 0.0% (0 of 2) |
Esophagus | N/A | heterozygote | 0.0% (0 of 2) |
Eye | N/A | heterozygote | 0.0% (0 of 2) |
Gall bladder | N/A | heterozygote | 0.0% (0 of 2) |
Heart | N/A | heterozygote | 0.0% (0 of 2) |
Hippocampus | N/A | heterozygote | 0.0% (0 of 2) |
Hypothalamus | N/A | heterozygote | 0.0% (0 of 2) |
Kidney | N/A | heterozygote | 0.0% (0 of 2) |
Large intestine | N/A | heterozygote | 0.0% (0 of 2) |
Liver | N/A | heterozygote | 0.0% (0 of 2) |
Lower urinary tract | N/A | heterozygote | 0.0% (0 of 2) |
Lung | N/A | heterozygote | 0.0% (0 of 2) |
Lymph node | N/A | heterozygote | 0.0% (0 of 2) |
Mammary gland | N/A | heterozygote | 0.0% (0 of 2) |
Olfactory lobe | N/A | heterozygote | 0.0% (0 of 2) |
Oral epithelium | N/A | heterozygote | 0.0% (0 of 2) |
Oviduct | N/A | heterozygote | 0.0% (0 of 2) |
Pancreas | N/A | heterozygote | 0.0% (0 of 2) |
Parathyroid gland | N/A | heterozygote | 0.0% (0 of 2) |
Peripheral nervous system | N/A | heterozygote | 0.0% (0 of 2) |
Peyer's patch | N/A | heterozygote | 0.0% (0 of 2) |
Pituitary gland | N/A | heterozygote | 0.0% (0 of 2) |
Prostate gland | N/A | heterozygote | 0.0% (0 of 2) |
Skeletal muscle | N/A | heterozygote | 0.0% (0 of 2) |
Skin | N/A | heterozygote | 0.0% (0 of 2) |
Small intestine | N/A | heterozygote | 0.0% (0 of 2) |
Spinal cord | N/A | heterozygote | 0.0% (0 of 2) |
Spleen | N/A | heterozygote | 0.0% (0 of 2) |
Stomach | N/A | heterozygote | 0.0% (0 of 2) |
Striatum | N/A | heterozygote | 0.0% (0 of 2) |
Testis | N/A | heterozygote | 50% (1 of 2) |
Thymus | N/A | heterozygote | 0.0% (0 of 2) |
Thyroid gland | N/A | heterozygote | 0.0% (0 of 2) |
Trachea | N/A | heterozygote | 0.0% (0 of 2) |
Uterus | N/A | heterozygote | 0.0% (0 of 2) |
Vascular system | N/A | heterozygote | 0.0% (0 of 2) |
White adipose tissue | N/A | heterozygote | 0.0% (0 of 2) |
Background staining occurs in wild type mice and embryos at an incidental rate.
Anatomy | Background staining in controls (WT) |
---|---|
adrenal gland | 0.68% (4 of 585) |
aorta | 0.17% (1 of 580) |
bone | 0.0% |
brain | 0.85% (5 of 589) |
brainstem | 0.34% (2 of 591) |
brown adipose tissue | 0.0% |
cartilage tissue | 0.17% (1 of 591) |
cerebellum | 0.51% (3 of 588) |
cerebral cortex | 0.17% (1 of 589) |
esophagus | 1.68% (7 of 416) |
eye | 0.0% |
gall bladder | 0.0% |
heart | 0.34% (2 of 584) |
hippocampus | 0.34% (2 of 590) |
hypothalamus | 0.34% (2 of 588) |
kidney | 4.58% (27 of 589) |
large intestine | 5.27% (31 of 588) |
liver | 0.0% |
lower urinary tract | 0.17% (1 of 592) |
lung | 0.34% (2 of 586) |
lymph node | 0.17% (1 of 585) |
mammary gland | 0.0% |
olfactory lobe | 0.34% (2 of 591) |
oral epithelium | 0.0% |
ovary | 0.17% (1 of 590) |
oviduct | 0.0% |
pancreas | 0.85% (5 of 589) |
parathyroid gland | 0.18% (1 of 568) |
peripheral nervous system | 0.34% (2 of 590) |
peyers patch | 0.0% |
pituitary gland | 0.17% (1 of 590) |
prostate gland | 2.21% (13 of 589) |
skeletal muscle | 0.0% |
skin | 0.17% (1 of 591) |
small intestine | 5.23% (31 of 593) |
spinal cord | 0.51% (3 of 592) |
spleen | 0.51% (3 of 587) |
stomach | 3.78% (22 of 582) |
striatum | 0.51% (3 of 587) |
testis | 1.01% (6 of 595) |
thymus | 0.17% (1 of 594) |
thyroid gland | 2.91% (17 of 585) |
trachea | 0.51% (3 of 587) |
uterus | 0.34% (2 of 588) |
vascular system | 0.0% |
white adipose tissue | 0.0% |
The analysis uses data from IMPC, along with published data on other mouse mutants, in comparison to human disease reports in OMIM, Orphanet, and DECIPHER.
Phenotype comparisons summarize the similarity of mouse phenotypes with human disease phenotypes.
The table below shows human diseases predicted to be associated to BC048562 by phenotypic similarity.
Disease | Similarity of phenotypes |
Matching phenotypes | Source |
---|---|---|---|
Severe Primary Trimethylaminuria | Emotional lability, Anxiety, Low self esteem, Aggressive behavior, Negative affectivity, Depression | ORPHA:468726 | |
Panic Disorder 1 | Anxiety | OMIM:167870 | |
Intellectual Developmental Disorder, Autosomal Recessive 25 | Anxiety | OMIM:614346 | |
Obsessive-Compulsive Disorder | Anxiety, Depression, Skin-picking | OMIM:164230 | |
Hyperinsulinemic Hypoglycemia, Familial, 7 | Hyperinsulinemic hypoglycemia, Hypoglycemia, Hypoglycemic seizures, Hyperinsulinemia | OMIM:610021 | |
Epilepsy, Progressive Myoclonic, 12 | Difficulty walking, Ataxia, Anxiety, Depression, Dysmetria | OMIM:619191 | |
Cone-Rod Synaptic Disorder Syndrome, Congenital Nonprogressive | Hyperglycemia, Anxiety, Ataxia | OMIM:618970 | |
Stiff Person Spectrum Disorder | Emotional lability, Agoraphobia, Difficulty walking, Falls, Diabetes mellitus, Anxiety | ORPHA:3198 |
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
MGI Allele | Allele Type | Produced |
---|---|---|
BC048562tm1a(KOMP)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | Mice, Targeting vectors, ES Cells |
BC048562tm1b(KOMP)Wtsi | Reporter-tagged deletion allele (with selection cassette) | Mice, Tissue |
BC048562tm1e(KOMP)Wtsi | Targeted, non-conditional allele | ES Cells |
Get highlights of the most important data releases, news and events, delivered straight to your email inbox
Subscribe to newsletter